Assignee
RADIONETICS ONCOLOGY INC
US·1 granted patent·4 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
5 records- 0161US2025213735A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0259US2026097139A1GONADOTROPIN-RELEASING HORMONE RECEPTOR (GnRHR) TARGETED THERAPEUTICS AND USES THEREOFRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0358US2024226343A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0457US2023405157A1Melanocortin type 2 receptor (mc2r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0545US12521455B2Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2025·Granted Jan 13, 2026·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when RADIONETICS ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →